Advertisement

Topics

Phase8 c/o Namesco Limited Company Profile

14:15 EDT 23rd June 2018 | BioPortfolio

Phase8 design and build high-end web sites for a growing number of clients ranging from sole traders to listed companies. Our web design and development solutions have been helping businesses to promote and market their products and services on the web since 1999.
We build web sites to suit you. We listen to your requirements and turn them into robust, scalable systems and high quality interface designs, all backed by Namesco Limited's award winning hosting and domain name registration infrastructure.

Phase8 is the web development arm of Namesco Limited. We are the 7th largest domain name and hosting provider within the UK Domain and Hosting sector, managing over 212,000 domain names and nearly 23,000 web sites at our data centre at Telehouse in London Docklands.

Location

Acton House
Perdiswell Park
Worcester
Worcestershire
WR3 7GD
United Kingdom

Contact

Phone: 0845 363 3636
Fax: 0845 363 3631
Email: studio@phase8.com


News Articles [29 Associated News Articles listed on BioPortfolio]

Genetic Technologies Limited: Update on Strategic Alliance

MELBOURNE, Australia, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ:GENE) (“Company”, “GTG”), wishes to advise that the Company is presently in discussi...

Quotient Limited to Host Investor Day on July 16, 2018

JERSEY, Channel Islands, June 18, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that it will host an Investor Day on Monday, July ...

Genetic Technologies Limited: Project Shivom Strategic Alliance

MELBOURNE, Australia, March 06, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG)  (NASDAQ:GENE) (“Company”, “GTG”) a diversified molecular diagnostics company; provider of...

Immutep Limited Announces Milestone Payment From Chinese Partner EOC Pharma

SYDNEY, Australia, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX:IMM) (NASDAQ:IMMP) announced today that it has received a milestone payment from the Company’s Chinese partner for efti...

Quotient Limited appoints Franz Walt as Chief Executive Officer

JERSEY, Channel Islands, May 29, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the appointment of Franz Walt, as its Chief Executi...

Quotient Limited Reports Commencement of EU Blood Grouping Field Trial

JERSEY, Channel Islands, May 17, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today reported that it has completed the verification and validatio...

Quotient Limited Announces Appointment of Franz Walt as Non-Executive Director

JERSEY, Channel Islands, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the appointment of Franz Walt to its board of...

Quotient Limited to Participate in the LEERINK Partners 7th Annual Global Healthcare Conference

JERSEY, Channel Islands, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive ...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [84 Associated Companies listed on BioPortfolio]

Phase8 c/o Namesco Limited

Phase8 design and build high-end web sites for a growing number of clients ranging from sole traders to listed companies. Our web design and development solutions have been helping businesses to promo...

Namesco Limited

Namesco Limited as you see us today began as 2 separate Internet start-ups in 1996 and 1997 as Names.co Internet Services Limited and Webcall.com Limited who merged in late 2000.Since then, through ca...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

SIEMENS CANADA LIMITED

More Information about "Phase8 c/o Namesco Limited" on BioPortfolio

We have published hundreds of Phase8 c/o Namesco Limited news stories on BioPortfolio along with dozens of Phase8 c/o Namesco Limited Clinical Trials and PubMed Articles about Phase8 c/o Namesco Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Phase8 c/o Namesco Limited Companies in our database. You can also find out about relevant Phase8 c/o Namesco Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record